m+Medelevator.RU
← Поиск публикаций
Future microbiology · 2025

Microbial isolates and resistance profiles in cerebrospinal fluid cultures: a five-year experience at a tertiary center.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gürler Merve, Kırca Füsun, Türen Figen, Kılınç İrem Tümkaya, Aslan Ferhat Gürkan, Salman Emrah, Çöplü Nilay, Dinç Bedia

Аннотация

PURPOSE: Central nervous system infections are a significant global health concern that results in morbidity and mortality. In case of these infections, empirical antibiotic treatment should be initiated according to the microbiological findings of the cerebrospinal fluid (CSF), and the treatment should be rearranged according to the antibiogram results.The study aimed to determine the distribution of meningitis agents and antimicrobial resistance patterns in our hospital.

METHODS: A total of 17,594 CSF culture samples collected from January 2020 to December 2024 were analyzed retrospectively. The study assessed demographic data, causative microorganisms, and antimicrobial resistance rates.

RESULTS: Positive results were found in 7.3% of CSF culture samples, with 69.1% being gram-positive bacteria and 30.9% gram-negative bacteria. The highest positivity rate was detected in the palliative inpatient clinic (14.8%) despite most cultures being from the neonatal intensive care unit (23.5%). The most common microorganisms were coagulase-negative staphylococci(CoNS) (47.9%) and Klebsiella pneumoniae (K.pneumoniae) (9.1%). Methicillin resistance was present in 89.7% of CoNS, and the rate of extended-spectrum β-lactamase-producing strains in K.pneumoniae was 32.4%.

CONCLUSION: Analysis of five-year data revealed the types of microorganisms and their antimicrobial resistance in positive CSF cultures. These findings will guide clinicians in promptly choosing the most effective empirical treatment.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты